Chemours Co. (CC) Shares Up 6.9%
Chemours Co. (NYSE:CC)’s share price shot up 6.9% during mid-day trading on Thursday . The company traded as high as $6.62 and last traded at $6.34, with a volume of 6,229,914 shares changing hands. The stock had previously closed at $5.93.
A number of brokerages recently issued reports on CC. Jefferies Group reiterated a “hold” rating on shares of Chemours in a research report on Wednesday, June 15th. Barclays PLC raised their price objective on shares of Chemours from $14.00 to $15.00 and gave the company an “overweight” rating in a research report on Monday, May 9th. Zacks Investment Research lowered shares of Chemours from a “buy” rating to a “hold” rating in a research report on Tuesday, May 10th. Goldman Sachs Group Inc. upgraded shares of Chemours from a “neutral” rating to a “buy” rating and raised their price objective for the company from $6.00 to $10.00 in a research report on Monday, March 14th. Finally, Vetr lowered shares of Chemours from a “hold” rating to a “sell” rating and set a $7.56 price objective for the company. in a research report on Wednesday, June 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $10.01.
The stock’s market capitalization is $1.18 billion. The company’s 50 day moving average price is $8.84 and its 200-day moving average price is $6.93.
Chemours (NYSE:CC) last announced its quarterly earnings data on Monday, May 2nd. The company reported $0.06 EPS for the quarter, topping the Zacks’ consensus estimate of $0.02 by $0.04. The firm earned $1.30 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the business earned $0.33 earnings per share. Chemours’s revenue for the quarter was down 4.8% compared to the same quarter last year. On average, equities research analysts predict that Chemours Co. will post $0.68 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, June 15th. Stockholders of record on Tuesday, May 17th were given a dividend of $0.03 per share. The ex-dividend date was Friday, May 13th. This represents a $0.12 annualized dividend and a dividend yield of 2.02%.
In other Chemours news, Director Bradley J. Bell acquired 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 4th. The stock was acquired at an average cost of $9.65 per share, for a total transaction of $96,500.00. Following the transaction, the director now owns 21,747 shares of the company’s stock, valued at $209,858.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Mark Newman acquired 2,800 shares of the firm’s stock in a transaction that occurred on Friday, May 13th. The stock was acquired at an average price of $9.71 per share, with a total value of $27,188.00. Following the completion of the transaction, the chief financial officer now directly owns 108,533 shares in the company, valued at approximately $1,053,855.43. The disclosure for this purchase can be found here.
Several institutional investors have modified their holdings of CC. Retirement Systems of Alabama raised its position in shares of Chemours by 1.3% in the fourth quarter. Retirement Systems of Alabama now owns 232,559 shares of the company’s stock valued at $1,247,000 after buying an additional 3,045 shares in the last quarter. Brown Advisory Inc. raised its position in shares of Chemours by 9.1% in the fourth quarter. Brown Advisory Inc. now owns 246,270 shares of the company’s stock valued at $1,320,000 after buying an additional 20,561 shares in the last quarter. Cornerstone Capital Management Holdings LLC. raised its position in shares of Chemours by 54.0% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 277,881 shares of the company’s stock valued at $1,489,000 after buying an additional 97,430 shares in the last quarter. Anchor Capital Advisors LLC acquired a new position in shares of Chemours during the fourth quarter valued at about $1,557,000. Finally, State of Wisconsin Investment Board raised its position in shares of Chemours by 6.8% in the fourth quarter. State of Wisconsin Investment Board now owns 402,390 shares of the company’s stock valued at $2,157,000 after buying an additional 25,620 shares in the last quarter.
The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.